139 related articles for article (PubMed ID: 3105004)
21. Lupus anticoagulant and HIV infection: a prospective study.
Boue F; Dreyfus M; Bridey F; Delfraissy JF; Dormont J; Tchernia G
AIDS; 1990 May; 4(5):467-8. PubMed ID: 2115343
[No Abstract] [Full Text] [Related]
22. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia.
Jouhikainen T; Kekomäki R; Leirisalo-Repo M; Bäcklund T; Myllylä G
Eur J Haematol; 1990 Apr; 44(4):234-9. PubMed ID: 2111779
[TBL] [Abstract][Full Text] [Related]
23. Plasma requirement for expression of lupus-like anticoagulant.
Clyne LP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999
[TBL] [Abstract][Full Text] [Related]
24. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis.
Freyssinet JM; Wiesel ML; Gauchy J; Boneu B; Cazenave JP
Thromb Haemost; 1986 Jun; 55(3):309-13. PubMed ID: 3018955
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous left ventricle cavity thrombus in a patient of systemic lupus erythematosus.
Barjatiya MK; Shah NK; Kothari SS; Shah PP; Trivedi HL
J Assoc Physicians India; 1992 Mar; 40(3):195-6. PubMed ID: 1634487
[TBL] [Abstract][Full Text] [Related]
26. Skin lesions associated with circulating lupus anticoagulant.
Alegre VA; Gastineau DA; Winkelmann RK
Br J Dermatol; 1989 Mar; 120(3):419-29. PubMed ID: 2496741
[TBL] [Abstract][Full Text] [Related]
27. Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.
Reisin LH; Reisin I; Darawshi A; Aviel E
Ann Ophthalmol; 1989 Jul; 21(7):269-71. PubMed ID: 2505658
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant--the Sneddon syndrome. Report of 10 cases.
Alegre VA; Winkelmann RK; Gastineau DA
Int J Dermatol; 1990; 29(1):45-9. PubMed ID: 2109736
[TBL] [Abstract][Full Text] [Related]
29. [A case of systemic lupus erythematosus with multiple organ thromboses].
Anzai K; Nagasawa K; Yao T; Yokota E; Otsuka T; Mayumi T; Niho Y
Nihon Naika Gakkai Zasshi; 1989 May; 78(5):650-4. PubMed ID: 2504851
[No Abstract] [Full Text] [Related]
30. Lupus anticoagulant and thrombosis of kidney allograft vessels.
Marcén R; Pascual J; Quereda C; Pardo A; Mampaso F; Orofino L; Teruel JL; Ortuño J
Transplant Proc; 1990 Aug; 22(4):1396-8. PubMed ID: 2117789
[No Abstract] [Full Text] [Related]
31. [Plasma coagulation and fibrinolysis in systemic lupus erythematosus (author's transl)].
Arnalich Fernández F; Gil Aguado A; Enríquez L; Navarro JL; Barbado Hernández FJ; Vázquez Rodríguez JJ
Med Clin (Barc); 1979 Jun; 73(1):5-10. PubMed ID: 470505
[No Abstract] [Full Text] [Related]
32. The multiple clinical aspects of lupus.
Godeau P; Piette JC; Francès C; Lê Thi Huong Du; Blétry O; Wechsler B
Clin Exp Rheumatol; 1990; 8 Suppl 5():27-35. PubMed ID: 2123136
[TBL] [Abstract][Full Text] [Related]
33. Splenic infarction. A new thrombotic manifestation of the circulating lupus anticoagulant.
Obarski TP; Stoller JK; Weinstein C; Hayden S
Cleve Clin J Med; 1989; 56(2):174-6. PubMed ID: 2499427
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for thrombosis in lupus patients.
Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG
Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
[TBL] [Abstract][Full Text] [Related]
35. [Streptokinase therapy in a patient with lupus anticoagulant and thrombosis of the A. iliaca externa].
Funk N; Stoyanova-Scholz M; Martin M; Bergerhausen HJ; Genth E; Fiebach BJ; Magnus L
Vasa; 1989; 18(4):318-21. PubMed ID: 2514521
[TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory observations in eight patients with lupus-type circulating anticoagulant.
Canciani MT; Maspero ML; Cattaneo M; Mannucci PM
Haematologica; 1979 Jun; 64(3):309-21. PubMed ID: 113299
[No Abstract] [Full Text] [Related]
37. [Cerebral infarct in a patient with systemic lupus erythematosus. The presence of lupus anticoagulant and Libman-Sacks endocarditis].
Labarga Echeverría P; Antón Botella F; Pinilla Moraza J; Milazo Estefanía A
Med Clin (Barc); 1992 Jun; 99(2):75. PubMed ID: 1630185
[No Abstract] [Full Text] [Related]
38. Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations.
Padmakumar K; Singh RR; Rai R; Malaviya AN; Saraya AK
Ann Rheum Dis; 1990 Dec; 49(12):986-9. PubMed ID: 2125409
[TBL] [Abstract][Full Text] [Related]
39. [Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus].
Wysocka K; Kiczak J; Pozorska D
Wiad Lek; 1977 Jul; 30(14):1129-34. PubMed ID: 888437
[No Abstract] [Full Text] [Related]
40. [Wide-spectrum effects of lupus anticoagulant in a patient with complex immunopathologic processes].
Barkagan ZS; Morozova LI; Serdiuk GV; Sukhanova GA; Kosikhin EN
Gematol Transfuziol; 1989 Jun; 34(6):25-31. PubMed ID: 2509280
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
